selenomethylselenocysteine has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abohamza, E; Berry, T; Moustafa, AA | 1 |
| Du, X; Iqbal, J; Li, X; Liu, Q; Liu, X; Shen, L; Shi, Q; Xie, Y; Zhang, H; Zhao, Y | 1 |
| Du, X; Liu, Q; Ni, J; Qu, X; Wang, B; Xie, Y; Zhang, Y; Zheng, L | 1 |
1 review(s) available for selenomethylselenocysteine and Alzheimer Disease
| Article | Year |
|---|---|
A disease-modifying treatment for Alzheimer's disease: focus on the trans-sulfuration pathway.
Topics: Alzheimer Disease; Animals; Homocysteine; Humans; Molybdenum; Neuroprotective Agents; Selenocysteine | 2020 |
2 other study(ies) available for selenomethylselenocysteine and Alzheimer Disease
| Article | Year |
|---|---|
Se-Methylselenocysteine (SMC) Improves Cognitive Deficits by Attenuating Synaptic and Metabolic Abnormalities in Alzheimer's Mice Model: A Proteomic Study.
Topics: Alzheimer Disease; Animals; Cognition; Disease Models, Animal; Mice; Mice, Transgenic; Proteomics; Selenium; Selenocysteine | 2021 |
Se-Methylselenocysteine Ameliorates Neuropathology and Cognitive Deficits by Attenuating Oxidative Stress and Metal Dyshomeostasis in Alzheimer Model Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Homeostasis; Male; MAP Kinase Signaling System; Metals; Mice, Transgenic; Neurons; Oxidative Stress; Phosphorylation; Selenocysteine; Spatial Memory; tau Proteins | 2018 |